SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-046720
Filing Date
2008-03-05
Accepted
2008-03-04 20:18:26
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1360180
2 FORM OF RESTRICTED STOCK UNIT GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT dex10318.htm EX-10.318 30173
3 FORM OF AMENDMENT TO RESTRICTED STOCK AGREEMENT dex10319.htm EX-10.319 7214
4 AMENDMENT TO RESTRICTED STOCK AGREEMENT dex10320.htm EX-10.320 6850
5 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6551
6 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6562
7 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4477
8 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4509
9 GRAPHIC g50195g65d60.jpg GRAPHIC 51819
  Complete submission text file 0001193125-08-046720.txt   1499470
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 08665843
SIC: 2834 Pharmaceutical Preparations